European Society of Toxicology In Vitro > Affiated Jounal – TIV > Special Issues > 2018 Special Issue: Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity
17 January 2020

2018 Special Issue: Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity

Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity

Edited by Wilhelmus de Jong, Bas J. Blaauboer, Kelly P. Coleman

  1. Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol Helena Kandárová, Hana Bendova, Silvia Letasiova, Kelly P. Coleman, … Dagmar Jírova. August 2018, Pages 433-438
  2. Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™ Helena Kandarova, Jamin A. Willoughby, Wim H. De Jong, Silvia Letasiova, … Kelly P. Coleman. August 2018, Pages 407-417
  3. Preparation of irritant polymer samples for an in vitro round robin study Kelly P. Coleman, Thomas P. Grailer, Lori R. McNamara, Beau L. Rollins, … Wim H. De Jong. August 2018, Pages 401-406.
  4. Reconstructed human epidermis models for irritant testing of medical devices Wim H. De Jong, Kelly P. Coleman, Bas J. Blaauboer. August 2018, Pages 399-400.
  5. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts Christian Pellevoisin, Christelle Videau, Damien Briotet, Corinne Grégoire, … Nathalie Seyler. August 2018, Pages 418-425.
  6. Round robin study to evaluate the reconstructed human epidermis (RhE) model as an in vitro skin irritation test for detection of irritant activity in medical device extracts Wim H. De Jong, Sebastian Hoffmann, Michelle Lee, Helena Kandárová, … Kelly P. Coleman. August 2018, Pages 439-449.
  7. Assessment of test method variables for in vitro skin irritation testing of medical device extracts Daniel S. Olsen, Michelle Lee, Audrey P. Turley. August 2018, Pages 426-432.

Related content

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on: Biobanking, In silico tools, Serum-free approaches and Educational resources. Prompt publishing and no submission or publication fees payable.

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment – with Gary Marchant, PhD, JD, Sandra Day O’Connor College of Law, Arizona State U. and Kirk T. Hartley, JD, ToxicoGenomica and LSP Group LLC

Webinar + Guidance on gaining acceptance in next generation PBK modelling approaches for regulatory approaches – May 10, 2021

  • News

If you are from the community of PBK model developers, or the proponent of a model in a regulatory submission, or a regulator who needs to assess the applicability of the models in chemical evaluations, this webinar is for you!

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding